Biocept, Inc.
BIOC · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $1,975 | $3,013 | $5,175 |
| - Cash | $6,633 | $6,774 | $12,897 | $18,021 |
| + Debt | $11,591 | $11,583 | $12,109 | $12,262 |
| Enterprise Value | $4,958 | $6,784 | $2,225 | -$584 |
| Revenue | $589 | $673 | -$10,285 | $5,587 |
| % Growth | -12.5% | 106.5% | -284.1% | – |
| Gross Profit | -$1,961 | -$2,355 | -$14,592 | -$189 |
| % Margin | -332.9% | -349.9% | 141.9% | -3.4% |
| EBITDA | -$3,211 | -$6,484 | -$18,162 | -$5,086 |
| % Margin | -545.2% | -963.4% | 176.6% | -91% |
| Net Income | -$3,631 | -$7,236 | -$18,522 | -$5,513 |
| % Margin | -616.5% | -1,075.2% | 180.1% | -98.7% |
| EPS Diluted | -3,503.04 | -12.32 | -32.57 | -9.73 |
| % Growth | -28,333.8% | 62.2% | -234.7% | – |
| Operating Cash Flow | -$3,086 | -$6,194 | -$4,242 | -$4,075 |
| Capital Expenditures | -$97 | -$91 | -$136 | -$356 |
| Free Cash Flow | -$3,183 | -$6,285 | -$4,378 | -$4,431 |